Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Google DeepMind has officially launched Gemma 3n, the latest version of its lightweight generative AI model designed ...

Google DeepMind has officially launched Gemma 3n, the latest version of its lightweight generative AI model designed ...

NOAA will be collaborating with Google's DeepMind and will evaluate the new models and provide feedback to Google's AI ...

Mark Zuckerberg has pulled off another top-flight coup in Silicon Valley's raging AI talent war by hiring Apple's chief of ...

Meta is pouring up to $100 million into top AI talent from OpenAI, DeepMind, and Anthropic. Here's more about their education ...

The decision to end the service was ultimately made by the US Department of Defense (DoD) and affects data collected by the ...

Still, Apple’s market share hasn't collapsed. iOS still beats Android in many regions, and macOS continues to chip away at Windows’ dominance. But if Apple can’t convince users its AI strategy is ...

Sten Saluveer, Strategic Advisor and Head of the Cannes Next Innovation Summit, the Marché Du Film’s tech-focused think tank, ...

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Computers can help ensure that mathematical proofs are correct, but translating traditional maths into a machine-readable ...

A public feud over model originality threatens China’s collaborative AI front, with Huawei denying whistleblower claims of ...